Organizing pneumonia following Covid19 pneumonia.

Fibrosis Inflammatory lung disease Interstitial lung disease Long Covid Pulmonary infection

Journal

Wiener klinische Wochenschrift
ISSN: 1613-7671
Titre abrégé: Wien Klin Wochenschr
Pays: Austria
ID NLM: 21620870R

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 11 02 2021
accepted: 16 03 2021
revised: 24 02 2021
pubmed: 17 4 2021
medline: 18 9 2021
entrez: 16 4 2021
Statut: ppublish

Résumé

The potential mid-term and long-term consequences after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections are as yet unknown. This is the first report of bronchoscopically verified organizing pneumonia as a complication of coronavirus disease 2019 (Covid19). It caused persisting dyspnea, impaired pulmonary function, and radiological abnormalities over 5 weeks after onset of symptoms. While organizing pneumonia frequently requires treatment with systemic corticosteroids, in this case it resolved spontaneously without treatment after 6 weeks. Healthcare professionals should consider organizing pneumonia in patients with persisting respiratory symptoms after Covid19.

Identifiants

pubmed: 33861398
doi: 10.1007/s00508-021-01852-9
pii: 10.1007/s00508-021-01852-9
pmc: PMC8050821
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

979-982

Informations de copyright

© 2021. The Author(s).

Références

Mod Pathol. 2005 Jan;18(1):1-10
pubmed: 15272286
BMC Infect Dis. 2019 Jul 29;19(1):671
pubmed: 31357937
N Engl J Med. 2003 May 15;348(20):1986-94
pubmed: 12682352
Zhonghua Bing Li Xue Za Zhi. 2004 Aug;33(4):354-7
pubmed: 15363323
Eur Respir J. 2006 Aug;28(2):422-46
pubmed: 16880372
J Clin Pathol. 2004 Mar;57(3):260-5
pubmed: 14990596
J Crit Care. 2020 Oct;59:149-155
pubmed: 32674001
Lancet Respir Med. 2020 May;8(5):438-440
pubmed: 32220663
J Formos Med Assoc. 2005 Feb;104(2):75-81
pubmed: 15765160
Thorax. 2008 Sep;63 Suppl 5:v1-58
pubmed: 18757459
J Thorac Dis. 2016 Oct;8(10):E1190-E1194
pubmed: 27867585
BMC Infect Dis. 2017 Aug 15;17(1):572
pubmed: 28810835
N Engl J Med. 2020 May 21;382(21):2049-2055
pubmed: 32202722
J Infect. 2020 Jul;81(1):e13-e20
pubmed: 32283144
Diagn Interv Imaging. 2020 May;101(5):263-268
pubmed: 32291197
BMJ Open Respir Res. 2020 Sep;7(1):
pubmed: 32963028
Medicine (Baltimore). 2020 Aug 28;99(35):e21804
pubmed: 32871900
Radiographics. 2013 Nov-Dec;33(7):1951-75
pubmed: 24224590
Radiol Cardiothorac Imaging. 2020 Mar 30;2(2):e200075
pubmed: 33778562
Chest. 2020 Apr;157(4):e99-e101
pubmed: 32087216
AJR Am J Roentgenol. 2020 Jul;215(1):87-93
pubmed: 32174129
Radiology. 2020 Aug;296(2):E55-E64
pubmed: 32191587
Radiology. 2020 Jun;295(3):715-721
pubmed: 32053470
Chest. 2020 Jul;158(1):106-116
pubmed: 32275978

Auteurs

Georg-Christian Funk (GC)

2nd Medical Department with Pneumology, Klinik Ottakring, Montleartstraße 37, 1160, Vienna, Austria. georg-christian.funk@gesundheitsverbund.at.
Karl-Landsteiner-Institute for Lung Research and Pulmonary Oncology, Montleartstraße 37, 1160, Vienna, Austria. georg-christian.funk@gesundheitsverbund.at.
Medical University of Vienna, Vienna, Austria. georg-christian.funk@gesundheitsverbund.at.

Caroline Nell (C)

2nd Medical Department with Pneumology, Klinik Ottakring, Montleartstraße 37, 1160, Vienna, Austria.
Karl-Landsteiner-Institute for Lung Research and Pulmonary Oncology, Montleartstraße 37, 1160, Vienna, Austria.

Wolfgang Pokieser (W)

Department of Pathology, Klinik Ottakring, Montleartstraße 37, 1160, Vienna, Austria.

Birgit Thaler (B)

2nd Medical Department with Pneumology, Klinik Ottakring, Montleartstraße 37, 1160, Vienna, Austria.

Gernot Rainer (G)

IMED 19, Billrothstraße 49, 1190, Vienna, Austria.

Arschang Valipour (A)

Karl-Landsteiner-Institute for Lung Research and Pulmonary Oncology, Montleartstraße 37, 1160, Vienna, Austria.
Department of Respiratory and Critical Care Medicine, Klinik Floridsdorf, Brünnerstraße 68, 1210, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH